| The mevalonate pathway is a druggable target for vaccine adjuvant discovery Y Xia, Y Xie, Z Yu, H Xiao, G Jiang, X Zhou, Y Yang, X Li, M Zhao, L Li, ... Cell 175 (4), 1059-1073. e21, 2018 | 202 | 2018 |
| Farnesyl pyrophosphate synthase as a target for drug development: Discovery of natural-product-derived inhibitors and their activity in pancreatic cancer cells S Han, X Li, Y Xia, Z Yu, N Cai, SR Malwal, X Han, E Oldfield, Y Zhang Journal of Medicinal Chemistry 62 (23), 10867-10896, 2019 | 30 | 2019 |
| Immunological activity difference between native calreticulin monomers and oligomers M He, J Wang, J Wu, F Gong, C Hong, Y Xia, L Zhang, W Bao, XM Gao PLoS One 9 (8), e105502, 2014 | 9 | 2014 |
| CD1dhiCD5+ B cells differentiate into antibody-secreting cells under the stimulation with calreticulin fragment T Zhang, Y Xia, L Zhang, W Bao, C Hong, XM Gao Protein & cell 4 (11), 872-881, 2013 | 7 | 2013 |
| Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment M Huang, Y Xia, K Li, F Shao, Z Feng, T Li, M Azin, S Demehri The Journal of Clinical Investigation 133 (20), 2023 | 2 | 2023 |
| Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin HG Son, DT Ha, Y Xia, T Li, J Blandin, T Oka, M Azin, DN Conrad, C Zhou, ... Cancer Cell, 2024 | | 2024 |
| Cutaneotropic polyomavirus abundance in the nonlesional skin of keratinocyte carcinoma patients: A cross-sectional study EY Zhou, Y Xia, T Oka, H Higuchi, T Hasegawa, JH Park, E Marchese, ... Journal of the American Academy of Dermatology 91 (5), 974-976, 2024 | | 2024 |
